Le Lézard
Classified in: Health
Subjects: POL, AVO

Dialysis Vascular Access Coalition: Final CMS Rule Puts Dialysis Patients At Risk


Dialysis Vascular Access Coalition (DVAC) is calling on Congress to take action and halt cuts to vascular access services included in the finalized 2024 Medicare Physician Fee Schedule (MPFS) Rule.

WASHINGTON, Nov. 15, 2023 /PRNewswire-PRWeb/ -- Today, the Dialysis Vascular Access Coalition (DVAC) is calling on Congress to take action and halt cuts to vascular access services included in the finalized 2024 Medicare Physician Fee Schedule (MPFS) Rule.

Dr. Dean Preddie, DVAC's policy chair, said, "Should the final rule remain in place, it will significantly curtail patient access to life-saving care. These cuts are unsustainable and are putting providers out of business and exposing patients to greater risk of serious illness and even death.

Due to the finalized rule, office-based dialysis vascular access services will again be cut by another 6 - 7% in 2024 alone. As a result of the 2022 PFS, office-based dialysis vascular access services will see their reimbursement decreased in some cases by more than 20% through 2025. Medicare. These year-over-year cuts are being implemented without regard to patient outcomes, actual PFS provider resource needs, or any other rationale policy. Since 2017, at least 30% of office-based dialysis vascular access centers have closed in large part to ongoing Medicare cuts.

DVAC strongly supports the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674), introduced by Rep. Gus Bilirakis (R-FL-12), Rep. Tony Cardenas (D-CA-29), Rep. Greg Murphy, MD (R-NC-3), and Rep. Danny Davis (IL-D-7). This bipartisan legislation will prevent ongoing cuts to office-based specialists for the next two years. By doing so, it will help stop major disruptions for dialysis patients.

Dr. Dean Preddie, DVAC's policy chair, said, "Should the final rule remain in place, it will significantly curtail patient access to life-saving care. These cuts are unsustainable and are putting providers out of business and exposing patients to greater risk of serious illness and even death. Congress must pass H.R. 3674, the "Providing Relief and Stability for Medicare Patients Act of 2023," which would stop the ongoing cuts to office-based specialists. This is important legislation that will address insufficient Medicare physician payments and ensure the continuity of vital office-based specialty care, preventing specialists from closing their doors and leaving patients in the cold."

Media Contact

Grant Herring, Dialysis Vascular Access Coalition, 202-280-2554, [email protected]https://www.dialysisvascularaccess.org/

SOURCE Dialysis Vascular Access Coalition


These press releases may also interest you

3 mai 2024
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...

3 mai 2024
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

3 mai 2024
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

3 mai 2024
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

3 mai 2024
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

3 mai 2024
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...



News published on and distributed by: